期刊
NEUROTHERAPEUTICS
卷 8, 期 1, 页码 72-81出版社
SPRINGER
DOI: 10.1007/s13311-010-0007-z
关键词
Positron emission tomography; single photon emission computed tomography; functional magnetic resonance imaging; dopamine; monoamines
资金
- Canadian Institutes of Health Research
- The Michael Smith Foundation for Health Research
- Pacific Alzheimer Research Foundation
- Canada Research Chairs program
Parkinson's disease (PD) is a common disorder in which the primary features can be related to dopamine deficiency. Changes on structural imaging are limited, but a wealth of abnormalities can be detected using positron emission tomography, single photon emission computed tomography, or functional magnetic resonance imaging to detect changes in neurochemical pathology or functional connectivity. The changes detected on these studies may reflect the disease process itself and/or compensatory responses to the disease, or they may arise in association with disease- and/or treatment-related complications. This review will focus mainly on neurochemical and metabolic studies and reviews various approaches to the assessment of dopaminergic function as well as the function of other neurotransmitters that may be affected in PD. A number of clinical applications are highlighted, including diagnostic utility, identification of preclinical disease, changes associated with motor and nonmotor complications of PD, and the effects of various therapeutic interventions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据